Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0Z2YQ
|
|||
| Former ID |
DIB011671
|
|||
| Drug Name |
Patiromer calcium
|
|||
| Synonyms |
Patiromer; RLY-5016; Potassium binder (hyperkalemia), Relypsa
Click to Show/Hide
|
|||
| Indication | Hyperkalemia [ICD-11: 5C76; ICD-10: E87.5] | Approved | [1] | |
| Company |
Relypsa Inc
|
|||
| ADReCS Drug ID | BADD_D01686 | |||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Potassium (K) | Target Info | Binder | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01810939) A Two-Part, Single-Blind, Phase 3 Study Evaluating the Efficacy and Safety of Patiromer for the Treatment of Hyperkalemia. U.S. National Institutes of Health. | |||
| REF 2 | Evaluation of the efficacy and safety of RLY5016, a polymeric potassium binder, in a double-blind, placebo-controlled study in patients with chronic heart failure (the PEARL-HF) trial. Eur Heart J. 2011 Apr;32(7):820-8. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.